These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17929453)

  • 1. [Immunoglobulin therapy for neurologic diseases].
    Nomura K
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):2046-53. PubMed ID: 17929453
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of immune neuropathies with intravenous immunoglobulins.
    Gold R; Kieseier BC
    J Neurol; 2006 Sep; 253 Suppl 5():V59-63. PubMed ID: 16998755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
    Lewańska M; Selmaj K
    Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
    Koichihara R; Hamano S; Yamashita S; Tanaka M
    Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
    Dalakas MC
    Ann Neurol; 2002 Jun; 51(6):667-9. PubMed ID: 12112069
    [No Abstract]   [Full Text] [Related]  

  • 10. Landry Guillian-Barre Strohl syndrome in pregnancy: use of high-dose intravenous immunoglobulin.
    Seoud M; Naboulsi M; Khalil A; Sarouphim P; Azar G; Khalifeh R
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):912-3. PubMed ID: 10577623
    [No Abstract]   [Full Text] [Related]  

  • 11. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
    Iannaccone S; Sferrazza B; Quattrini A; Smirne S; Ferini-Strambi L
    Neurology; 1999 Sep; 53(5):1154-5. PubMed ID: 10496291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravenous immunoglobulin therapy in neuroimmunological disorders].
    Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barré syndrome: rare extra-intestinal manifestation of hepatitis B.
    Sonavane AD; Saigal S; Kathuria A; Choudhary NS; Saraf N
    Clin J Gastroenterol; 2018 Aug; 11(4):312-314. PubMed ID: 29542024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin and Guillain-Barré syndrome.
    Harel M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras.
    Koul R; Chacko A; Ahmed R; Varghese T; Javed H; Al-Lamki Z
    J Child Neurol; 2003 Nov; 18(11):767-71. PubMed ID: 14696904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Guillain-Barré syndrome with corticosteroids: lack of benefit?
    Hughes RA
    Lancet; 2004 Jan; 363(9404):181-2. PubMed ID: 14738786
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
    Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
    J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroids in the Guillain-Barré syndrome: is there a therapeutic window?
    Van Koningsveld R; Van Doorn PA
    Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470
    [No Abstract]   [Full Text] [Related]  

  • 20. Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis.
    Ortiz-Salas P; Velez-Van-Meerbeke A; Galvis-Gomez CA; Rodriguez Q JH
    J Clin Neuromuscul Dis; 2016 Sep; 18(1):1-11. PubMed ID: 27552383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.